Evaluating the Promiscuous Nature of Tyrosine Kinase Inhibitors Assessed in A431 Epidermoid Carcinoma Cells by Both Chemical- and Phosphoproteomics
May 14th, 2014 by Piero Giansanti, Christian Preisinger, Kilian V. M. Huber, Manuela Gridling, Giulio Superti-Furga, Keiryn L. Bennett and Albert J. R. Heck
ACS Chemical Biology
DOI: 10.1021/cb500116c